- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02439762
Intervening to Reduce Suicide Risk in Veterans With Substance Use Disorders
September 22, 2022 updated by: Mark A. Ilgen, University of Michigan
The purpose of this study is to evaluate the impact of a Cognitive Behavioral Therapy (CBT) intervention compared to a Supportive Psycho-educational Control (SPC) condition in reducing the frequency and intensity of suicidal thoughts and behaviors in Veterans with Substance Use Disorders (SUDs) over a two-year follow-up period.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The project is a multi-site randomized controlled trial of the CBT intervention versus the SPC condition for 300 suicidal Veterans seen in Veterans Health Administration (VHA) intensive outpatient substance treatment programs (SUD IOP).
Participants will be screened for current suicidal ideation and other conditions by completing a self-report survey questionnaire.
Eligible participants will complete a baseline assessment which will include a self-report survey questionnaire, a research staff administered interview, and a voluntary urine drug screen.
Participants will be randomized to either a Cognitive Behavior Therapy (CBT) or Supportive Psycho-education Control (SPC) condition.
Both conditions will involve receipt of 8 one-on-one sessions lasting approximately one hour over a period of approximately 3-4 weeks in addition to their standard SUD IOP treatment of care they may be receiving at the VAMC.
The intervention is designed to augment their current treatment, not to take the place of current treatment.
Participants will be re-assessed immediately after receiving the study interventions (at 1-month) and then again at 3-, 6- 12-, 18-, and 24-month post-intervention follow-ups by completing a series of self-report surveys, researcher administered interviews, and a voluntary urine drug screen.
To ensure adequate monitoring of suicidal ideation, additional telephone follow-up assessments will occur 2-, 4-, and 5-months post-intervention.
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80907
- Colorado Springs, Colorado Community-Based Outpatient Clinic
-
Denver, Colorado, United States, 80220
- VA Eastern Colorado Health Care System
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48105
- VA Ann Arbor Healthcare System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must be 18 years of age or older
- Must be a United States Military Veteran
- Report current suicidal ideation
- Enrolled in outpatient substance abuse treatment within the past month
- Must live within 75 miles of treatment site at time of recruitment
Exclusion Criteria:
- Inability to give informed, voluntary, written consent
- Inability to speak and understand English
- Receipt of methadone treatment for substance use currently or within the past 6 months
- Evidence of active, severe psychotic symptoms
- Women who are currently pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Behavioral Therapy (CBT)
The CBT condition will cover topics such as orienting the patient to the cognitive model of suicidal thoughts, plans and behaviors and the role of substance use in increasing the likelihood of suicidal behaviors and presenting tools to help patients better manage responses to suicide-related triggers.
|
The therapeutic intervention group consists of 8, one-hour individual therapy sessions delivered over the course of 3-4 weeks with a trained CBT therapist.
These sessions are designed to provide beneficial coping strategies that are helpful in dealing with both substance use and suicidal thoughts.
|
|
Active Comparator: Supportive Psycho-education (SPC)
The SPC condition is designed to match the CBT condition in terms of level of attention and the non-specific aspects of receiving support for a suicidal crisis and substance misuse.
Specific content related to suicide risk will consist of general information about suicide-related resources available, while content related to substance use is based on a modified psycho-educational attention control treatment for alcoholism.
The sessions will help patients to better understand the resources available during a suicidal crisis and how substance use impacts in their life.
However, topics related to identifying thoughts and behaviors associated with suicidal crises and possible coping mechanisms will not be a part of the formal content of these SPC sessions.
|
This active control condition consists of 8, one-hour individual therapy sessions delivered over the course of 3-4 weeks with a trained therapist.
The sessions will provide detailed information about substance use, suicide risk, and depression to those enrolled.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in frequency and intensity of suicidal thoughts and suicide attempts
Time Frame: Change over study time period [Baseline, 1-, 3-, 6-, 12-, 18-, and 24-months]
|
This will be measured using the Columbia Suicide Severity Rating Scale (CSS-RS) and a modified version of the Time Line Follow-Back (TLFB).
|
Change over study time period [Baseline, 1-, 3-, 6-, 12-, 18-, and 24-months]
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2015
Primary Completion (Actual)
June 12, 2020
Study Completion (Actual)
June 12, 2020
Study Registration Dates
First Submitted
May 1, 2015
First Submitted That Met QC Criteria
May 6, 2015
First Posted (Estimate)
May 12, 2015
Study Record Updates
Last Update Posted (Actual)
September 23, 2022
Last Update Submitted That Met QC Criteria
September 22, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- W81XWH 14-1-0005
- Log Number 11224006 (Other Grant/Funding Number: US Army Medical Research and Materiel Command)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance-Related Disorders
-
University of Wisconsin, MadisonNational Institute on Drug Abuse (NIDA); Rush University Medical CenterCompletedSubstance-Related Disorders | Substance Use | Substance AbuseUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem
-
US Department of Veterans AffairsCompletedAlcoholism | Substance Use Disorders | Substance Abuse | Alcohol Abuse | Substance DependenceUnited States
-
VA Office of Research and DevelopmentActive, not recruiting
-
National Institute on Drug Abuse (NIDA)CompletedSubstance-related Disorders
-
Norwegian University of Science and TechnologyCompletedSubstance-related DisordersNorway
-
University Hospital, Basel, SwitzerlandPsychiatric Hospital of the University of BaselCompleted
-
University of LuebeckFederal Ministry of Health, GermanyCompletedSubstance-related Disorders
-
University of Illinois at Urbana-ChampaignCompletedSubstance-related Disorders
-
University of NebraskaCompletedSubstance-related Disorders | Alcohol-related DisordersUnited States
Clinical Trials on Cognitive Behavioral Therapy (CBT)
-
University of California, Los AngelesNational Institute of Nursing Research (NINR)Completed
-
Universitat Jaume IMinisterio de Ciencia e Innovación, SpainCompletedSexual Compulsive Behavior Disorder | Cybersex Addiction | Online Compulsive Sexual BehaviorSpain
-
Massachusetts General HospitalActive, not recruitingDepression | Obsessive Compulsive Disorder | Generalized Anxiety Disorder | Attention Deficit Hyperactivity Disorder | Trichotillomania | Panic Disorder | Social Phobia | Specific Phobia | Tourette Syndrome | Post-Traumatic Stress Disorder | Body Dysmorphic Disorder | Eating Disorder | General Medical ConditionUnited States
-
Emory UniversityAlzheimer's AssociationCompleted
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)CompletedSomatoform Disorders | Body Dysmorphic DisorderUnited States
-
The University of Texas Health Science Center at...59th Medical Wing; Brooke Army Medical Center; South Texas Veterans Health Care...CompletedCombat Disorders | Post-Traumatic Stress Disorders | Stress DisordersUnited States
-
Jimmi NielsenRecruitingTreatment-resistant Schizophrenia | Treatment-refractory SchizophreniaDenmark
-
University of FloridaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDepression | Traumatic Brain InjuryUnited States